Loss of KDM6A characterizes a poor prognostic subtype of human pancreatic cancer and potentiates HDAC inhibitor lethalityShuichi Watanabe, Shinji Tanaka, Shu Shimada et al.|International Journal of Cancer|2018Cited by 64
Surgical pitfalls of jejunal vein anatomy in pancreaticoduodenectomyYoshiya Ishikawa, Minoru Tanabe, Daisuke Ban et al.|Journal of Hepato-Biliary-Pancreatic Sciences|2017Cited by 46
C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancerHiroaki Ono, Minoru Tanabe, Yoshimitsu Akiyama et al.|Scientific Reports|2021Cited by 43
RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeling in pancreatic cancerHiroaki Ono, Minoru Tanabe, Yoshiki Murase et al.|International Journal of Oncology|2023Cited by 34
Prediction of early recurrence of pancreatic ductal adenocarcinoma after resectionToshitaka Sugawara, Minoru Tanabe, Daisuke Ban et al.|PLoS ONE|2021Cited by 27